Granted Patent
B2
US 7,691,905 · App. 10/746,206 · Granted Apr 6, 2010
Inhibition of melanogenesis and melanoma metastasis with p-aminobenzoic acid (PABA)
Assignee:
New York University
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention relates to the inhibition of melanogenesis with para-aminobenzoic acid (PABA) and its use in treating melanotic cancer.
Claims (4)
1. A method for treating a patient with malignant melanoma comprising administering a combination of carboplatin, paclitaxel, and p-aminobenzoic acid (PABA) to the patient with malignant melanoma.
2. The method of claim 1 wherein the patient with malignant melanoma has metastatic malignant melanoma.
3. The method of claim 1 wherein the patient with malignant melanoma has recurrent malignant melanoma.
4. The method of claim 1 wherein the patient with malignant melanoma has non-responsive malignant melanoma.
Assignments (2)
CONFIRMATORY LICENSE
Recorded Jul 19, 2013
From: NEW YORK UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 030832/0203 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded May 4, 2004
From: BROOKS, PETER C.; MORAIS, DANIELLE; RODRIGUEZ, DOROTHY
To: NEW YORK UNIVERSITY
Reel/Frame 015311/0839 →
Continuity (2)
Provisional Application
6043639400
· Dec 24, 2002